東華大學圖書館 |

Influenza = advances in diagnosis and management /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Influenza/ edited by Jiro Fujita.
其他題名:	advances in diagnosis and management /
其他作者:	Fujita, Jiro.
出版者:	Singapore :Springer Singapore : : 2021.,
面頁冊數:	ix, 229 p. :ill. (some col.), digital ;24 cm.
內容註:	Part I Introduction -- 1. Global strategy for influenza viral infection: What is the latest Information from WHO? -- Part II Definition, Epidemiology, and Pathogenesis -- 2. Epidemiology of influenza with a description of recent trends in Japan: What are the key epidemiologic features of seasonal influenza in terms of time, place, person, and virus (overall and in Japan)? -- 3. Transmission of influenza virus in the home: How are they transmitted in the home? -- 4. Cellular and biochemical pathogenic processes in severe influenza virus infection: How does cytokine storm plays a role? -- 5. Pathology of severe influenza virus pneumonia: what is the importance of alveolar mouths? -- 6. Pathology, Diagnosis, and Treatment of Influenza Infections/Pneumonia: What are the mechanisms of secondary bacterial pneumonia? -- Part III Diagnosis -- 7. Rapid diagnosis of influenza viral infection: What are the rapid diagnostic tests and molecular diagnosis? -- 8. Differential diagnosis between influenza and other respiratory viral infections: What are the differential diagnoses? -- 9. Radiologic findings of influenza pneumonia: What are the recent radiological findings? -- 10. Oral findings of influenza viral infection: What are the characteristic pharyngeal findings of influenza? -- Part IV Complication -- 11. Classification of pneumonia complicated with influenza viral infection: What are the patterns of pneumonia? -- 12. Influenza encephalopathy: What is encephalopathy? -- Part V Management -- 13. Treatment guidelines for influenza virus infection: What does the recent guideline state? -- 14. Treatment strategy for influenza viral infection in adolescent: what is the current adolescent treatment? -- 15. How to use anti-influenza drugs: zanamivir and oseltamivir -- 16. How to use anti-influenza drugs: laninamivir octanoate -- 17. How to use anti-influenza drugs: baloxavir marboxil -- 18. How to use anti-influenza drugs: peramivir -- 19. Prophylaxis of influenza viral transmission: What is the current prophylaxis? -- Part VI Topics -- 20. Influenza vaccine efficacy/effectiveness: with special reference to current epidemiological methodology -- 21. The new anti-influenza drug baloxavir marboxil: Can influenza viruses with reduced susceptibility to baloxavir maintain viral fitness? -- 22. Viruses resistant to oseltamivir or baloxavir: What do the data reveal about resistance?.
Contained By:	Springer Nature eBook
標題:	Influenza. -
電子資源:	https://doi.org/10.1007/978-981-15-9109-9
ISBN:	9789811591099

Influenza = advances in diagnosis and management /
Influenzaadvances in diagnosis and management /[electronic resource] :edited by Jiro Fujita. - Singapore :Springer Singapore :2021. - ix, 229 p. :ill. (some col.), digital ;24 cm. - Respiratory disease series: diagnostic tools and disease managements,2509-5552. - Respiratory disease series..

Part I Introduction -- 1. Global strategy for influenza viral infection: What is the latest Information from WHO? -- Part II Definition, Epidemiology, and Pathogenesis -- 2. Epidemiology of influenza with a description of recent trends in Japan: What are the key epidemiologic features of seasonal influenza in terms of time, place, person, and virus (overall and in Japan)? -- 3. Transmission of influenza virus in the home: How are they transmitted in the home? -- 4. Cellular and biochemical pathogenic processes in severe influenza virus infection: How does cytokine storm plays a role? -- 5. Pathology of severe influenza virus pneumonia: what is the importance of alveolar mouths? -- 6. Pathology, Diagnosis, and Treatment of Influenza Infections/Pneumonia: What are the mechanisms of secondary bacterial pneumonia? -- Part III Diagnosis -- 7. Rapid diagnosis of influenza viral infection: What are the rapid diagnostic tests and molecular diagnosis? -- 8. Differential diagnosis between influenza and other respiratory viral infections: What are the differential diagnoses? -- 9. Radiologic findings of influenza pneumonia: What are the recent radiological findings? -- 10. Oral findings of influenza viral infection: What are the characteristic pharyngeal findings of influenza? -- Part IV Complication -- 11. Classification of pneumonia complicated with influenza viral infection: What are the patterns of pneumonia? -- 12. Influenza encephalopathy: What is encephalopathy? -- Part V Management -- 13. Treatment guidelines for influenza virus infection: What does the recent guideline state? -- 14. Treatment strategy for influenza viral infection in adolescent: what is the current adolescent treatment? -- 15. How to use anti-influenza drugs: zanamivir and oseltamivir -- 16. How to use anti-influenza drugs: laninamivir octanoate -- 17. How to use anti-influenza drugs: baloxavir marboxil -- 18. How to use anti-influenza drugs: peramivir -- 19. Prophylaxis of influenza viral transmission: What is the current prophylaxis? -- Part VI Topics -- 20. Influenza vaccine efficacy/effectiveness: with special reference to current epidemiological methodology -- 21. The new anti-influenza drug baloxavir marboxil: Can influenza viruses with reduced susceptibility to baloxavir maintain viral fitness? -- 22. Viruses resistant to oseltamivir or baloxavir: What do the data reveal about resistance?.

This book explores the latest research and practical data on the clinical management of influenza. Starting with the definition, epidemiology and pathogenesis, the first part reviews the basic science of the influenza virus and infection. The next three parts then discusses the diagnosis, complications and management, providing practical data and insights that are useful in day-to-day patient care. The last part focuses on the trending topics, including a new drug, oral baloxavir marboxil, which was introduced in Japan in 2018 and is the first polymerase inhibitor to be licensed for the treatment of uncomplicated influenza. In Japan, since the medical insurance system is well-established, patients receive medical examinations quickly after the onset of influenza viral infection, making it easy to implement early diagnostic tools and early treatment. Providing practical data and insights, Influenza - Advances in Diagnosis and Management is a useful resource for clinicians, residents and trainees around the globe.

ISBN: 9789811591099

Standard No.: 10.1007/978-981-15-9109-9doiSubjects--Topical Terms:

924085
Influenza.

LC Class. No.: RC150 / .I54 2021

Dewey Class. No.: 616.203

National Library of Medicine Call No.: WC 515

Influenza = advances in diagnosis and management /
LDR:04533nmm a2200349 a 4500 001 2236522
003 DE-He213
005 20201110124930.0
006 m d
007 cr nn 008maaau
008 211111s2021 si s 0 eng d
020 $a 9789811591099 $q (electronic bk.)
020 $a 9789811591082 $q (paper)
024 7 $a 10.1007/978-981-15-9109-9 $2 doi
035 $a 978-981-15-9109-9
040 $a GP $c GP $e rda
041 0 $a eng
050 4 $a RC150 $b .I54 2021
060 4 $a WC 515
072 7 $a MJCJ $2 bicssc
072 7 $a MED022090 $2 bisacsh
072 7 $a MJCJ $2 thema
082 0 4 $a 616.203 $2 23
090 $a RC150 $b .I43 2021
245 0 0 $a Influenza $h [electronic resource] : $b advances in diagnosis and management / $c edited by Jiro Fujita.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a ix, 229 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Respiratory disease series: diagnostic tools and disease managements, $x 2509-5552
505 0 $a Part I Introduction -- 1. Global strategy for influenza viral infection: What is the latest Information from WHO? -- Part II Definition, Epidemiology, and Pathogenesis -- 2. Epidemiology of influenza with a description of recent trends in Japan: What are the key epidemiologic features of seasonal influenza in terms of time, place, person, and virus (overall and in Japan)? -- 3. Transmission of influenza virus in the home: How are they transmitted in the home? -- 4. Cellular and biochemical pathogenic processes in severe influenza virus infection: How does cytokine storm plays a role? -- 5. Pathology of severe influenza virus pneumonia: what is the importance of alveolar mouths? -- 6. Pathology, Diagnosis, and Treatment of Influenza Infections/Pneumonia: What are the mechanisms of secondary bacterial pneumonia? -- Part III Diagnosis -- 7. Rapid diagnosis of influenza viral infection: What are the rapid diagnostic tests and molecular diagnosis? -- 8. Differential diagnosis between influenza and other respiratory viral infections: What are the differential diagnoses? -- 9. Radiologic findings of influenza pneumonia: What are the recent radiological findings? -- 10. Oral findings of influenza viral infection: What are the characteristic pharyngeal findings of influenza? -- Part IV Complication -- 11. Classification of pneumonia complicated with influenza viral infection: What are the patterns of pneumonia? -- 12. Influenza encephalopathy: What is encephalopathy? -- Part V Management -- 13. Treatment guidelines for influenza virus infection: What does the recent guideline state? -- 14. Treatment strategy for influenza viral infection in adolescent: what is the current adolescent treatment? -- 15. How to use anti-influenza drugs: zanamivir and oseltamivir -- 16. How to use anti-influenza drugs: laninamivir octanoate -- 17. How to use anti-influenza drugs: baloxavir marboxil -- 18. How to use anti-influenza drugs: peramivir -- 19. Prophylaxis of influenza viral transmission: What is the current prophylaxis? -- Part VI Topics -- 20. Influenza vaccine efficacy/effectiveness: with special reference to current epidemiological methodology -- 21. The new anti-influenza drug baloxavir marboxil: Can influenza viruses with reduced susceptibility to baloxavir maintain viral fitness? -- 22. Viruses resistant to oseltamivir or baloxavir: What do the data reveal about resistance?.
520 $a This book explores the latest research and practical data on the clinical management of influenza. Starting with the definition, epidemiology and pathogenesis, the first part reviews the basic science of the influenza virus and infection. The next three parts then discusses the diagnosis, complications and management, providing practical data and insights that are useful in day-to-day patient care. The last part focuses on the trending topics, including a new drug, oral baloxavir marboxil, which was introduced in Japan in 2018 and is the first polymerase inhibitor to be licensed for the treatment of uncomplicated influenza. In Japan, since the medical insurance system is well-established, patients receive medical examinations quickly after the onset of influenza viral infection, making it easy to implement early diagnostic tools and early treatment. Providing practical data and insights, Influenza - Advances in Diagnosis and Management is a useful resource for clinicians, residents and trainees around the globe.
650 0 $a Influenza. $3 924085
650 0 $a Influenza $x Diagnosis. $3 3488021
650 0 $a Influenza $x Treatment. $3 3488022
650 1 4 $a Infectious Diseases. $3 894100
650 2 4 $a Pneumology/Respiratory System. $3 894348
650 2 4 $a Immunology. $3 611031
650 2 4 $a Vaccine. $3 1001012
650 2 4 $a Health Promotion and Disease Prevention. $3 894308
700 1 $a Fujita, Jiro. $3 3488020
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Respiratory disease series. $3 3217866
856 4 0 $u https://doi.org/10.1007/978-981-15-9109-9
950 $a Medicine (SpringerNature-11650)